Healthcare -
Biotechnology - NASDAQ - US
$ 0.4938
-2.87 %
$ 57.5 M
Market Cap
-0.35
P/E
Price Target
Average
811.30%
Revenue Forecast
Estimate
133.13%
EBIT
Estimate
47.01%
Net Income
Estimate
40.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Applied Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for APLT of $4.5 , with forecasts ranging from
a
low of
$4 to a high of $5 .
APLT Lowest Price Target
Wall Street Target
4 USD
710.04%
APLT Average Price Target
Wall Street Target
4.5 USD
811.30%
APLT Highest Price Target
Wall Street Target
5 USD
912.56%
REVENUE FORECAST
Revenue Forecast Chart APLT
EBIT FORECAST
EBIT Forecast Chart APLT
NET INCOME FORECAST
Net Income Chart APLT